CEMIP and cancer: The expression levels of KIAA1199 are increased in a number of cancer types12–15, and have been reported as a poor prognostic factor in patients with breast, colon cancer, and gastric cancer12,14,16,17, probably due to increased risk for metastasis15,18–20.